Abattis Bioceuticals Corp.
OTC: ATTBF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Robert G. Goodall
- Employees
- 48
- Headquarters
- Vancouver, Canada
- IPO year
- 2014
- Market cap
- $14.3K
- Website
- https://www.abattis.com
Loading ATTBF…
Loading profile data…Frequently asked questions about ATTBF
What does Abattis Bioceuticals Corp. (ATTBF) do?
Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammati...
Where does ATTBF trade?
Abattis Bioceuticals Corp. (ATTBF) trades on the Other OTC.
What sector is ATTBF in?
Abattis Bioceuticals Corp. (ATTBF) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Abattis Bioceuticals Corp.?
Robert G. Goodall is the chief executive officer of Abattis Bioceuticals Corp. (ATTBF).
Where is Abattis Bioceuticals Corp. headquartered?
Abattis Bioceuticals Corp. is headquartered in Canada.
Does ATTBF pay a dividend?
Abattis Bioceuticals Corp. (ATTBF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ATTBF go public?
Abattis Bioceuticals Corp. (ATTBF) completed its initial public offering in 2014.